| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Leukemia Section, Department of Medicine, Biopolymer Facility and Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263
Hematopoietic cytokine receptor signaling involves activation of signal
transducer and activator of transcription (STAT) proteins that are
thought to control cellular differentiation. Truncated STAT isoforms
(ß forms, rather than the normal
forms) have been described and
found to block the normal signaling function of the
isoforms. We
recently demonstrated STATß isoforms in bone marrow samples from 21
of 27 (78%) acute myeloid leukemia (AML) patients. We sought to
determine the mechanism by which the STATß forms were generated.
Samples from eight newly diagnosed AML patients were studied; four
expressed predominantly STAT
, and four expressed predominantly
STATß. The reverse transcription-PCR generated identical products in
the two groups, suggesting that alternate mRNA splicing is not
responsible for the genesis of STATß. Extracts from cells expressing
predominantly STATß incubated with cell extracts from the MO7E cell
line, which expresses predominantly STAT
, caused a decrease of the
isoforms and an increase of the ß isoforms, suggesting the
presence of proteolytic activity. This proteolytic activity was:
(a) specific for STAT3 and STAT5, but not for STAT6;
(b) serine dependent; (c) equally present
in nuclear and cytoplasmic fractions of the leukemic blasts; and
(d) different than the activity detected in a murine
hematopoietic cell line. The cleaved ß isoforms retained their
DNA-binding activity. Because expression of truncated STATs may be
involved in blocking differentiation of AML blasts, elucidation of the
regulation of the proteolytic activity may contribute to our
understanding of leukemogenesis.
This article has been cited by other articles:
![]() |
M. Benekli, H. Baumann, and M. Wetzler Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias J. Clin. Oncol., September 10, 2009; 27(26): 4422 - 4432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Redell, A. Tsimelzon, S. G. Hilsenbeck, and D. J. Tweardy Conditional overexpression of Stat3{alpha} in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern J. Leukoc. Biol., October 1, 2007; 82(4): 975 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Crotti, M. Lusic, R. Lupo, P. M. J. Lievens, E. Liboi, G. D. Chiara, M. Tinelli, A. Lazzarin, B. K. Patterson, M. Giacca, et al. Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression Blood, June 15, 2007; 109(12): 5380 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wetzler, J. C. Earp, M. T. Brady, M. K. Keng, and W. J. Jusko Synergism between Arsenic Trioxide and Heat Shock Protein 90 Inhibitors on Signal Transducer and Activator of Transcription Protein 3 Activity--Pharmacodynamic Drug-Drug Interaction Modeling Clin. Cancer Res., April 1, 2007; 13(7): 2261 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kato, E. Sakamoto, H. Kutsuna, A. Kimura-Eto, F. Hato, and S. Kitagawa Proteolytic Conversion of STAT3{alpha} to STAT3{gamma} in Human Neutrophils: ROLE OF GRANULE-DERIVED SERINE PROTEASES J. Biol. Chem., July 23, 2004; 279(30): 31076 - 31080. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler Signal transducer and activator of transcription proteins in leukemias Blood, April 15, 2003; 101(8): 2940 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sherman, D. R. Powell, and M. A. Brown IL-4 Induces the Proteolytic Processing of Mast Cell STAT6 J. Immunol., October 1, 2002; 169(7): 3811 - 3818. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Helander, J.-A. Gustafsson, and A. Mode Possible Involvement of Truncated Signal Transducer and Activator of Transcription-5 in the GH Pattern-Dependent Regulation of CYP2C12 Gene Expression in Rat Liver Mol. Endocrinol., July 1, 2002; 16(7): 1598 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benekli, Z. Xia, K. A. Donohue, L. A. Ford, L. A. Pixley, M. R. Baer, H. Baumann, and M. Wetzler Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival Blood, January 1, 2002; 99(1): 252 - 257. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |